- Home
- MED vs EPRX Comparison
MED vs EPRX Comparison
Compare MED & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- EPRX
- Stock Information
- Founded
- MED 1980
- EPRX 2011
- Country
- MED United States
- EPRX Canada
- Employees
- MED N/A
- EPRX N/A
- Industry
- MED Packaged Foods
- EPRX
- Sector
- MED Consumer Staples
- EPRX
- Exchange
- MED Nasdaq
- EPRX NYSE
- Market Cap
- MED 156.7M
- EPRX 130.0M
- IPO Year
- MED N/A
- EPRX N/A
- Fundamental
- Price
- MED $13.05
- EPRX $3.10
- Analyst Decision
- MED Hold
- EPRX Strong Buy
- Analyst Count
- MED 1
- EPRX 1
- Target Price
- MED $16.50
- EPRX $9.00
- AVG Volume (30 Days)
- MED 206.1K
- EPRX 11.5K
- Earning Date
- MED 04-28-2025
- EPRX 05-07-2025
- Dividend Yield
- MED N/A
- EPRX N/A
- EPS Growth
- MED N/A
- EPRX N/A
- EPS
- MED 0.19
- EPRX N/A
- Revenue
- MED $602,463,000.00
- EPRX N/A
- Revenue This Year
- MED N/A
- EPRX N/A
- Revenue Next Year
- MED $2.10
- EPRX N/A
- P/E Ratio
- MED $68.61
- EPRX N/A
- Revenue Growth
- MED N/A
- EPRX N/A
- 52 Week Low
- MED $12.87
- EPRX $2.20
- 52 Week High
- MED $36.30
- EPRX $4.48
- Technical
- Relative Strength Index (RSI)
- MED 37.76
- EPRX N/A
- Support Level
- MED $12.87
- EPRX N/A
- Resistance Level
- MED $13.71
- EPRX N/A
- Average True Range (ATR)
- MED 0.51
- EPRX 0.00
- MACD
- MED -0.05
- EPRX 0.00
- Stochastic Oscillator
- MED 9.78
- EPRX 0.00
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.